ASTRO Release: High Doses of Stereotactic Body Radiotherapy for Patients With Organ-Confined Prostate Cancer Shows High Relapse-Free Survival

Published: Oct 31, 2012

BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of traditional lengthy treatment courses or surgery, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting.

Back to news